208 related articles for article (PubMed ID: 9915885)
1. Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans.
Bouhnik Y; Vahedi K; Achour L; Attar A; Salfati J; Pochart P; Marteau P; Flourié B; Bornet F; Rambaud JC
J Nutr; 1999 Jan; 129(1):113-6. PubMed ID: 9915885
[TBL] [Abstract][Full Text] [Related]
2. Effects of fructo-oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon carcinogenesis in healthy humans.
Bouhnik Y; Flourié B; Riottot M; Bisetti N; Gailing MF; Guibert A; Bornet F; Rambaud JC
Nutr Cancer; 1996; 26(1):21-9. PubMed ID: 8844718
[TBL] [Abstract][Full Text] [Related]
3. The capacity of short-chain fructo-oligosaccharides to stimulate faecal bifidobacteria: a dose-response relationship study in healthy humans.
Bouhnik Y; Raskine L; Simoneau G; Paineau D; Bornet F
Nutr J; 2006 Mar; 5():8. PubMed ID: 16569219
[TBL] [Abstract][Full Text] [Related]
4. Four-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers.
Bouhnik Y; Achour L; Paineau D; Riottot M; Attar A; Bornet F
Nutr J; 2007 Dec; 6():42. PubMed ID: 18053236
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of fructo-oligosaccharides supplementation on fecal bifidobacteria and index of peroxidation status in constipated nursing-home residents--a placebo-controlled, diet-controlled trial.
Yen CH; Kuo YW; Tseng YH; Lee MC; Chen HL
Nutrition; 2011 Mar; 27(3):323-8. PubMed ID: 20579847
[TBL] [Abstract][Full Text] [Related]
6. Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans.
Bouhnik Y; Flourié B; D'Agay-Abensour L; Pochart P; Gramet G; Durand M; Rambaud JC
J Nutr; 1997 Mar; 127(3):444-8. PubMed ID: 9082028
[TBL] [Abstract][Full Text] [Related]
7. Prebiotic effect of fructo-oligosaccharide supplemented term infant formula at two concentrations compared with unsupplemented formula and human milk.
Euler AR; Mitchell DK; Kline R; Pickering LK
J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):157-64. PubMed ID: 15699689
[TBL] [Abstract][Full Text] [Related]
8. Impact of a jelly containing short-chain fructo-oligosaccharides and Sideritis euboea extract on human faecal microbiota.
Mitsou EK; Turunen K; Anapliotis P; Zisi D; Spiliotis V; Kyriacou A
Int J Food Microbiol; 2009 Oct; 135(2):112-7. PubMed ID: 19735957
[TBL] [Abstract][Full Text] [Related]
9. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study.
Bouhnik Y; Raskine L; Simoneau G; Vicaut E; Neut C; Flourié B; Brouns F; Bornet FR
Am J Clin Nutr; 2004 Dec; 80(6):1658-64. PubMed ID: 15585783
[TBL] [Abstract][Full Text] [Related]
10. Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans.
Bouhnik Y; Attar A; Joly FA; Riottot M; Dyard F; Flourié B
Eur J Clin Nutr; 2004 Mar; 58(3):462-6. PubMed ID: 14985684
[TBL] [Abstract][Full Text] [Related]
11. Fn-type chicory inulin hydrolysate has a prebiotic effect in humans.
Menne E; Guggenbuhl N; Roberfroid M
J Nutr; 2000 May; 130(5):1197-9. PubMed ID: 10801918
[TBL] [Abstract][Full Text] [Related]
12. Acidic oligosaccharides from pectin hydrolysate as new component for infant formulae: effect on intestinal flora, stool characteristics, and pH.
Fanaro S; Jelinek J; Stahl B; Boehm G; Kock R; Vigi V
J Pediatr Gastroenterol Nutr; 2005 Aug; 41(2):186-90. PubMed ID: 16056097
[TBL] [Abstract][Full Text] [Related]
13. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants.
Moro G; Minoli I; Mosca M; Fanaro S; Jelinek J; Stahl B; Boehm G
J Pediatr Gastroenterol Nutr; 2002 Mar; 34(3):291-5. PubMed ID: 11964956
[TBL] [Abstract][Full Text] [Related]
14. Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis.
Lara-Villoslada F; de Haro O; Camuesco D; Comalada M; Velasco J; Zarzuelo A; Xaus J; Galvez J
Eur J Nutr; 2006 Oct; 45(7):418-25. PubMed ID: 16871370
[TBL] [Abstract][Full Text] [Related]
15. Effects of a new mixture of prebiotics on faecal flora and stools in term infants.
Moro GE; Mosca F; Miniello V; Fanaro S; Jelinek J; Stahl B; Boehm G
Acta Paediatr Suppl; 2003 Sep; 91(441):77-9. PubMed ID: 14599046
[TBL] [Abstract][Full Text] [Related]
16. Soyoligosaccharide increases fecal bifidobacteria counts, short-chain fatty acids, and fecal lipid concentrations in young Korean women.
Bang MH; Chio OS; Kim WK
J Med Food; 2007 Jun; 10(2):366-70. PubMed ID: 17651076
[TBL] [Abstract][Full Text] [Related]
17. Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial.
Holscher HD; Faust KL; Czerkies LA; Litov R; Ziegler EE; Lessin H; Hatch T; Sun S; Tappenden KA
JPEN J Parenter Enteral Nutr; 2012 Jan; 36(1 Suppl):95S-105S. PubMed ID: 22237884
[TBL] [Abstract][Full Text] [Related]
18. Dose-response effects of inulin and oligofructose on intestinal bifidogenesis effects.
Rao AV
J Nutr; 1999 Jul; 129(7 Suppl):1442S-5S. PubMed ID: 10395617
[TBL] [Abstract][Full Text] [Related]
19. Effects of Bifidobacterium sp fermented milk ingested with or without inulin on colonic bifidobacteria and enzymatic activities in healthy humans.
Bouhnik Y; Flourie B; Andrieux C; Bisetti N; Briet F; Rambaud JC
Eur J Clin Nutr; 1996 Apr; 50(4):269-73. PubMed ID: 8730616
[TBL] [Abstract][Full Text] [Related]
20. Effects of short-chain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals.
Giacco R; Clemente G; Luongo D; Lasorella G; Fiume I; Brouns F; Bornet F; Patti L; Cipriano P; Rivellese AA; Riccardi G
Clin Nutr; 2004 Jun; 23(3):331-40. PubMed ID: 15158296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
